Target intelligence / Profile preview

Cyclin E2 mRNA 3' untranslated region (CCNE2 mRNA 3' UTR)

Target
CCNE2 mRNA 3' UTR
Molecular classification
Nucleic acid, mRNA regulatory element
01

Overview

The CCNE2 mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the messenger RNA encoding Cyclin E2, a protein essential for the G1/S phase transition in the cell cycle. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translation efficiency of the CCNE2 transcript (Caldon et al., 2013, PubMed). In many cancers, including breast and lung cancer, the loss of inhibitory miRNA binding or the shortening of the 3' UTR leads to the overexpression of Cyclin E2, which drives uncontrolled cellular proliferation and contributes to endocrine therapy resistance (Balko et al., 2014, Nature Medicine). As a therapeutic target, the CCNE2 mRNA 3' UTR is primarily addressed using miRNA mimics or antisense oligonucleotides designed to restore translational repression or induce transcript degradation. By modulating this regulatory node, researchers aim to arrest the cell cycle in malignant cells and sensitize tumors to existing chemotherapeutic or endocrine agents.

Other names
CCNE2 3'-UTRCyclin E2 3'-UTRCCNE2 three prime untranslated region
02

Mechanism of action

MicroRNA-mediated gene silencing, mRNA degradation, Translational inhibition

03

Biological functions

Cell cycle regulationmRNA stability regulationTranslational controlG1/S transition
04

Disease associations

CancerBreast cancerNon-small cell lung cancerEndocrine resistance
05

Safety considerations

Off-target effects of RNA-based therapeuticsSystemic delivery challengesPotential disruption of normal hematopoietic or epithelial cell cycles
06

Interacting drugs

miR-30c mimics

2 more in the full profile.

07

Biomarkers

CCNE2 mRNA levelsmiR-30c expression levelsCyclin E2 protein expression

Beyond the preview

Go deeper on Cyclin E2 mRNA 3' untranslated region (CCNE2 mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin E2 mRNA 3' untranslated region (CCNE2 mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call